DWM
TMO icon

Darwin Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Darwin Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Hold
69
– – 0.01% 270
2026
Q1 		$34K Sell
69
-390
-85% -$212K 0.01% 254
2025
Q4 		$266K Buy
459
+9
+2% +$5.09K 0.08% 123
2025
Q3 		$218K Buy
450
+31
+7% +$14.4K 0.07% 128
2025
Q2 		$170K Sell
419
-7
-2% -$2.93K 0.06% 135
2025
Q1 		$222K Hold
426
– – 0.07% 126
2024
Q4 		$222K Sell
426
-10
-2% -$5.5K 0.07% 126
2024
Q3 		$270K Buy
+436
New +$258K 0.07% 123
2024
Q2 		– Sell
-430
Closed -$250K – 138
2024
Q1 		$250K Buy
430
+2
+0.5% +$1.12K 0.07% 114
2023
Q4 		$227K Sell
428
-93
-18% -$45K 0.06% 137
2023
Q3 		$264K Sell
521
-66
-11% -$35.2K 0.07% 123
2023
Q2 		$305K Buy
587
+158
+37% +$85.3K 0.08% 112
2023
Q1 		$253K Sell
429
-18
-4% -$10.1K 0.07% 140
2022
Q4 		$261K Sell
447
-10
-2% -$5.3K 0.07% 146
2022
Q3 		$236K Buy
+457
New +$256K 0.06% 141
2022
Q2 		– Sell
-1,340
Closed -$791K – 178
2022
Q1 		$791K Sell
1,340
-12
-0.9% -$6.89K 0.13% 99
2021
Q4 		$795K Buy
1,352
+266
+24% +$166K 0.13% 98
2021
Q3 		$620K Buy
1,086
+84
+8% +$46.1K 0.1% 105
2021
Q2 		$505K Sell
1,002
-5,615
-85% -$2.65M 0.08% 112
2021
Q1 		$3.02M Buy
6,617
+83
+1% +$39.6K 0.53% 51
2020
Q4 		$3.04M Buy
6,534
+5,896
+924% +$2.76M 0.57% 49
2020
Q3 		$281K Buy
638
+65
+11% +$26.9K 0.06% 131
2020
Q2 		$207K Hold
573
– – 0.05% 149
2020
Q1 		$162K Sell
573
-60
-9% -$18.9K 0.05% 149
2019
Q4 		$206K Buy
+633
New +$192K 0.05% 150

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Darwin Wealth Management's TMO Position: Q2 2026 in Review

Darwin Wealth Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 69 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #270.

Darwin Wealth Management first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.04M in Q4 2020. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Darwin Wealth Management held 69 shares of Thermo Fisher Scientific worth $35K as of Q2 2026.
  • Darwin Wealth Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #270 holding.
  • Darwin Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • Darwin Wealth Management's Thermo Fisher Scientific position peaked at $3.04M in Q4 2020.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.